Literature DB >> 24847186

Course of Hemoglobin and Hematocrit during and after Preparatory Plasmaphereses without and with Infusion of NaCl 0.9% 500 ml.

Josef Evers1, Norbert Ehren1, Tanja Engelen1, Michael Hansen1, Kerstin Luethje1, Uwe Taborski1.   

Abstract

BACKGROUND: The aim of this study was to evaluate the course of hemoglobin (HGB) concentration and hematocrit (HCT) in donor blood during and after preparatory plasmaphereses (PP) without NaCl and with an infusion of 500 ml 0.9% NaCl during PP.
METHODS: After informed consent 32 plasma donors were studied in a crossover design. They underwent PP once without NaCl infusion and once, on a different day, with infusion of 500 ml 0.9% NaCl. HGB concentration and HCT values in donor blood were analyzed using a Sysmex KX-21N analyzer. The values of HGB concentration and HCT before PP were set to 100%. Changes in HGB concentration and HCT were calculated in percent directly after PP, and after 24 and 72 h.
RESULTS: During PP, there was a notable change in HGB concentration (11.2 ± 4.0%) and HCT (11.6 ± 3.9%) in donor blood. The difference between the 2 samples without and with NaCl was highly significant (p < 0.001). After 24 and 72 h, all differences were reduced.
CONCLUSION: We observed significant changes in HGB concentration and HCT in donor blood during PP. We recommend a concomitant infusion of 500 ml 0.9% NaCl during PP to all donors.

Entities:  

Keywords:  Apheresis; Hematocrit; Hemoglobin; NaCl 0.9% infusion; Plasmapheresis

Year:  2014        PMID: 24847186      PMCID: PMC4025150          DOI: 10.1159/000354336

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  8 in total

1.  EFFECTS OF INTENSIVE PLASMAPHERESIS ON NORMAL BLOOD DONORS.

Authors:  A KLIMAN; P P CARBONE; L A GAYDOS; E J FREIREICH
Journal:  Blood       Date:  1964-05       Impact factor: 22.113

2.  Influence of NaCl 0.9% Infusion during Plasmapheresis on IgG Content in Plasma.

Authors:  Josef Evers; Jochen Betz; Thomas Blankenburg; Tanja Engelen; Gabriele Galle; Michael Hansen; Teija Laitinen; Uwe Taborski
Journal:  Transfus Med Hemother       Date:  2010-07-14       Impact factor: 3.747

3.  The effects of automated plasmapheresis on clinical, haematological, biochemical and coagulation variables in horses.

Authors:  K Feige; F B Ehrat; S B R Kästner; B Wampfler
Journal:  Vet J       Date:  2005-01       Impact factor: 2.688

Review 4.  On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications.

Authors:  Stefan Wellek; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2012-04-13       Impact factor: 5.594

5.  Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.

Authors:  Sudipta Sekhar Das; Rajendra Chaudhary; Sunil Kumar Verma; Shashank Ojha; Dheeraj Khetan
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

6.  A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis.

Authors:  Mark Buzza; Denese C Marks; Hugh Capper; Elisa Cassin; Caro-Anne Badcock; Samantha Reid; Matthew Kwok; Hung Yang; June Lee; Carolyn Corrigan; Tanja Hartkopf-Theis; Anthony Keller
Journal:  Transfusion       Date:  2012-02-20       Impact factor: 3.157

7.  Analysis of pre- and post-donation haematological values in plateletpheresis donors.

Authors:  E Love; K Pendry; L Hunt
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

8.  [Changes in blood rheology and microcirculation after preparatory combined thrombocytapheresis and plasmapheresis].

Authors:  B Mansouri Taleghani; F Manke; R Langer; H A Henrich; R Grossmann; R Hofmann; D Wiebecke
Journal:  Beitr Infusionsther Transfusionsmed       Date:  1997
  8 in total
  1 in total

1.  Unexpected Hypotensive Events during Preparatory Plasmaphereses.

Authors:  Josef Evers
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.